2) The expression of FAP may predict early presentation of CCRCC metastases to lymphatic nodes, 3) FAP is significantly associated with tumor aggressiveness and poor outcome of patients with mCCRCC and 4) The simultaneous expression of FAP in primary and metastatic tumors merits further investigation. This evidence concerns the gene FAP and nonpapillary renal cell carcinoma.